Renalytix Plc
RNLXY
$0.225
$0.00853.93%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 53.44% | 36.29% | 36.04% | 18.76% | 15.05% |
| Total Depreciation and Amortization | -52.76% | 50.00% | -46.92% | -35.71% | 41.11% |
| Total Amortization of Deferred Charges | -- | -50.00% | -- | -- | -- |
| Total Other Non-Cash Items | -52.75% | 580.71% | 9.66% | -40.88% | -35.13% |
| Change in Net Operating Assets | 93.94% | -202.17% | 3,770.00% | -100.93% | -183.09% |
| Cash from Operations | 59.64% | 9.35% | 51.87% | 3.80% | -33.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -101.69% | -160.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -100.00% | 100.00% | -2.04% | 0.00% |
| Issuance of Common Stock | -- | 5,735.17% | -75.01% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -106.77% | -56.01% | -- | -- |
| Cash from Financing | 102.16% | 8,047.96% | -77.61% | 13.78% | -12.82% |
| Foreign Exchange rate Adjustments | 118.92% | -95.72% | -106.43% | -90.72% | 90.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.05% | 99.71% | -109.93% | -14.51% | -4.84% |
